Hospital admissions in children with down syndrome: experience of a population-based cohort followed from birth

Patrick Fitzgerald1, Helen Leonard, Terri J Pikora

  • 1Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Crawley, Western Australia, Australia.

Plos One
|August 23, 2013
PubMed

Insights

Children with Down syndrome experience frequent hospitalizations, particularly for respiratory and ear conditions, highlighting the need for targeted primary care. These children are hospitalized five times more often than the general population.

Area of Science:

  • Pediatrics
  • Genetics
  • Public Health

Background:

  • Down syndrome is the most common genetic cause of intellectual disability.
  • Children with Down syndrome are susceptible to numerous health issues.
  • Understanding hospitalization patterns is crucial for managing their healthcare needs.

Purpose of the Study:

  • To describe hospitalization patterns in children and young people with Down syndrome in Western Australia.
  • To identify common reasons for hospital admission in this population.
  • To compare hospitalization rates with the general population.

Main Methods:

  • Linked birth records with the Western Australian Intellectual Disability database (1983-1999).
  • Connected identified individuals to the Hospital Morbidity Data System (up to 2004).
  • Analyzed hospitalization data using ICD-9CM and ICD-10 codes, calculating admission rates and lengths of stay.

Main Results:

  • 395 out of 405 children had 3786 hospital admissions (757.2 per 1000 person-years).
  • Upper respiratory tract conditions were most common (58.5%), followed by ear/hearing and oral cavity disorders.
  • Children with Down syndrome were hospitalized at five times the rate of the general population.

Conclusions:

  • Children with Down syndrome face increased morbidity from diverse causes.
  • Comprehensive and targeted primary care is essential for this population.
  • Findings underscore the need for proactive health management in Down syndrome.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.